In patient AML#2, we detected a frameshift insertion (c.6306_6307insCACC, p.P2102fs) of gene SETD2 in a considerable fraction of the tumor population both at diagnosis (MF 32.5%) and at relapse (MF 31.7%). The gene discussed is SETD2; the disease is neoplasm.